Portman Ridge (PTMN) came out with quarterly earnings of $0.47 per share, missing the Zacks Consensus Estimate of $0.60 per share. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -21.67%. A quarter ago, it was expected that this business development company would post earnings of $0.64 per share when it actually produced earnings of $0.60, delivering a surprise of -6.25%.Over the last four qu ...

Sun Life (SLF) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.10%. A quarter ago, it was expected that this financial services company would post earnings of $1.24 per share when it actually produced earnings of $1.20, delivering a surprise of -3.23%.Over the last four quarters, th ...

Core Viewpoint - ModivCare reported a significant quarterly loss of $1.71 per share, which was much worse than the Zacks Consensus Estimate of a loss of $0.34, indicating a substantial earnings surprise of -402.94% [1] Financial Performance - The company posted revenues of $650.65 million for the quarter ended March 2025, slightly exceeding the Zacks Consensus Estimate by 0.96%, but down from $684.45 million in the same quarter last year [2] - Over the last four quarters, ModivCare has surpassed consensus EPS estimates only once, while it has topped consensus revenue estimates two times [2] Stock Performance - ModivCare shares have declined approximately 88.6% since the beginning of the year, contrasting sharply with the S&P 500's decline of only -4.3% [3] Future Outlook - The company's earnings outlook is critical for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is -$0.06 on revenues of $653.77 million, and for the current fiscal year, it is -$0.16 on revenues of $2.64 billion [7] Industry Context - The Medical Services industry, to which ModivCare belongs, is currently ranked in the top 22% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Another company in the same industry, HealthEquity, is expected to report quarterly earnings of $0.81 per share, reflecting a year-over-year increase of 1.3% [9]

Globalstar (GSAT) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -42.86%. A quarter ago, it was expected that this satellite communications company would post a loss of $0.05 per share when it actually produced a loss of $0.14, delivering a surprise of -180%.Over the last four quarters, the ...

Information Services Group (III) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this market advisory service company would post earnings of $0.05 per share when it actually produced earnings of $0.06, delivering a surprise of 20%.Over the l ...

Company Performance - Innodata Inc. reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.17 per share, and significantly up from $0.03 per share a year ago, representing an earnings surprise of 29.41% [1] - The company posted revenues of $58.34 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.24%, and up from $26.5 million year-over-year [2] - Over the last four quarters, Innodata has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.21 on revenues of $60.44 million, and for the current fiscal year, it is $0.85 on revenues of $246.11 million [7] - The estimate revisions trend for Innodata is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Industry Context - The Computer - Services industry, to which Innodata belongs, is currently in the top 22% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

GrowGeneration (GRWG) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -14.29%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced a loss of $0.27, delivering a surprise of -50%.Over the last four quarters, the company has not been a ...

Nektar Therapeutics (NKTR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -22.22%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.13 per share when it actually produced a loss of $0.15, delivering a surprise of -15.38%.Over the last four quarters, ...

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 19.35%. A quarter ago, it was expected that this orthopedic medical device maker would post a loss of $0.03 per share when it actually produced a loss of $0.01, delivering a surprise of 66.67%.Over the last four qu ...

Company Performance - VAREX IMAGING reported quarterly earnings of $0.26 per share, exceeding the Zacks Consensus Estimate of $0.14 per share, and up from $0.16 per share a year ago, representing an earnings surprise of 85.71% [1] - The company posted revenues of $212.9 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 2.93%, compared to year-ago revenues of $206.2 million [2] - Over the last four quarters, VAREX IMAGING has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Performance and Outlook - VAREX IMAGING shares have declined approximately 44% since the beginning of the year, while the S&P 500 has decreased by 4.3% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the sustainability of the recent earnings numbers [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.16 on revenues of $207.93 million, and for the current fiscal year, it is $0.54 on revenues of $824.37 million [7] Industry Context - The Medical - Products industry, to which VAREX IMAGING belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact VAREX IMAGING's stock performance [5][6]